Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR]

INTRODUCTION: The urgent need for new treatments for multidrug-resistant tuberculosis (MDR-TB) and pre-extensively drug-resistant tuberculosis (pre-XDR-TB) is evident. However, the classic randomized controlled trial (RCT) approach faces ethical and practical constraints, making alternative research...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Liang, Xiong, Juan, Wang, Haibo, Zhang, Peize, Yang, Qianting, Cai, Yi, Wang, Wenfei, Sun, Feng, Zhang, Xilin, Wang, Zhaoqin, Chen, Xinchun, Zhang, Wenhong, Deng, Guofang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683225/
https://www.ncbi.nlm.nih.gov/pubmed/38012543
http://dx.doi.org/10.1186/s12879-023-08644-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683225/
https://www.ncbi.nlm.nih.gov/pubmed/38012543
http://dx.doi.org/10.1186/s12879-023-08644-8

Ejemplares similares